Abstract
The history of the establishment of safe residue levels is reviewed. Current internation agreements within the FAO/WHO Codex Alimentarius programme and EC legislation establish these levels on the basis of toxicology studies. In addition to conventional toxicological effects, other effects such as the effects of drugs on the immune system, and pharmacological effects should be taken into account. The latter also include specific effects of residues of veterinary antibiotics on the human gut flora. The methods for the assessment of these effects are evaluated. Studies in human volunteers enable the establishment of a no-effect level in conditions which are the most closely mimicking the conditions of use. However, they are less favourable from a practical and ethical point of view. Studies with animal models can be used; for example human intestinal flora can be inoculated to gnotobiotic mice. These models need nevertheless to be further validated. Studies in vitro, such as those to determine the MIC, are relatively simple to carry out and inexpensive, but are not always representative of the relevant bacteria, and may not take into account factors such as, Ph, anaerobiosis and the barrier effect.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.